These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29449434)

  • 41. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
    Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
    Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy.
    Campbell MR; Nation PN; Andrew SE
    Cancer Res; 2005 Apr; 65(7):2626-35. PubMed ID: 15805259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Compound heterozygosity for MSH6 mutations in a pediatric lymphoma patient.
    Peters A; Born H; Ettinger R; Levonian P; Jedele KB
    J Pediatr Hematol Oncol; 2009 Feb; 31(2):113-5. PubMed ID: 19194194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia.
    Evans WE; Horner M; Chu YQ; Kalwinsky D; Roberts WM
    J Pediatr; 1991 Dec; 119(6):985-9. PubMed ID: 1960624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells.
    Diouf B; Cheng Q; Krynetskaia NF; Yang W; Cheok M; Pei D; Fan Y; Cheng C; Krynetskiy EY; Geng H; Chen S; Thierfelder WE; Mullighan CG; Downing JR; Hsieh P; Pui CH; Relling MV; Evans WE
    Nat Med; 2011 Sep; 17(10):1298-303. PubMed ID: 21946537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Feasibility of monitoring peripheral blood to detect emerging clones in children with acute lymphoblastic leukemia
    Saliba J; Evensen NA; Meyer JA; Newman D; Nersting J; Narang S; Ma X; Schmiegelow K; Carroll WL
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28306. PubMed ID: 32391957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CRISPR/Cas9-Mediated Induction of Relapse-Specific
    Nguyen TTT; Tanaka Y; Sanada M; Hosaka M; Tamai M; Kagami K; Komatsu C; Somazu S; Harama D; Kasai S; Watanabe A; Akahane K; Goi K; Inukai T
    Mol Pharmacol; 2023 Apr; 103(4):199-210. PubMed ID: 36669880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutator phenotype in Msh2-deficient murine embryonic fibroblasts.
    Reitmair AH; Risley R; Bristow RG; Wilson T; Ganesh A; Jang A; Peacock J; Benchimol S; Hill RP; Mak TW; Fishel R; Meuth M
    Cancer Res; 1997 Sep; 57(17):3765-71. PubMed ID: 9288785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of rs62527607 [GT] single nucleotide polymorphism located in BAALC gene in children with acute leukemia using mismatch PCR-RFLP.
    Nadimi M; Rahgozar S; Moafi A; Tavassoli M; Mesrian Tanha H
    Cancer Genet; 2016; 209(7-8):348-53. PubMed ID: 27372260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
    Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
    Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
    Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
    PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Schmiegelow K; Forestier E; Kristinsson J; Söderhäll S; Vettenranta K; Weinshilboum R; Wesenberg F;
    Leukemia; 2009 Mar; 23(3):557-64. PubMed ID: 18987654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impaired transport as a mechanism of resistance to thiopurines in human T-lymphoblastic leukemia cells.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1039-44. PubMed ID: 17065061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DHFR and MSH3 co-amplification in childhood acute lymphoblastic leukaemia, in vitro and in vivo.
    Matheson EC; Hogarth LA; Case MC; Irving JA; Hall AG
    Carcinogenesis; 2007 Jun; 28(6):1341-6. PubMed ID: 17148505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of TPMT and ITPA variants in mercaptopurine disposition.
    Gerbek T; Ebbesen M; Nersting J; Frandsen TL; Appell ML; Schmiegelow K
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):579-586. PubMed ID: 29387964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.
    Pieters R; Hongo T; Loonen AH; Huismans DR; Broxterman HJ; Hählen K; Veerman AJ
    Br J Cancer; 1992 May; 65(5):691-7. PubMed ID: 1350207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The MitoNEET Ligand NL-1 Mediates Antileukemic Activity in Drug-Resistant B-Cell Acute Lymphoblastic Leukemia.
    Geldenhuys WJ; Nair RR; Piktel D; Martin KH; Gibson LF
    J Pharmacol Exp Ther; 2019 Jul; 370(1):25-34. PubMed ID: 31010844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.
    Fink D; Nebel S; Norris PS; Aebi S; Kim HK; Haas M; Howell SB
    Br J Cancer; 1998 Mar; 77(5):703-8. PubMed ID: 9514047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.